Vascular resistance

Revision as of 15:50, 6 September 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Vascular resistance

Articles

Most recent articles on Vascular resistance

Most cited articles on Vascular resistance

Review articles on Vascular resistance

Articles on Vascular resistance in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Vascular resistance

Images of Vascular resistance

Photos of Vascular resistance

Podcasts & MP3s on Vascular resistance

Videos on Vascular resistance

Evidence Based Medicine

Cochrane Collaboration on Vascular resistance

Bandolier on Vascular resistance

TRIP on Vascular resistance

Clinical Trials

Ongoing Trials on Vascular resistance at Clinical Trials.gov

Trial results on Vascular resistance

Clinical Trials on Vascular resistance at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Vascular resistance

NICE Guidance on Vascular resistance

NHS PRODIGY Guidance

FDA on Vascular resistance

CDC on Vascular resistance

Books

Books on Vascular resistance

News

Vascular resistance in the news

Be alerted to news on Vascular resistance

News trends on Vascular resistance

Commentary

Blogs on Vascular resistance

Definitions

Definitions of Vascular resistance

Patient Resources / Community

Patient resources on Vascular resistance

Discussion groups on Vascular resistance

Patient Handouts on Vascular resistance

Directions to Hospitals Treating Vascular resistance

Risk calculators and risk factors for Vascular resistance

Healthcare Provider Resources

Symptoms of Vascular resistance

Causes & Risk Factors for Vascular resistance

Diagnostic studies for Vascular resistance

Treatment of Vascular resistance

Continuing Medical Education (CME)

CME Programs on Vascular resistance

International

Vascular resistance en Espanol

Vascular resistance en Francais

Business

Vascular resistance in the Marketplace

Patents on Vascular resistance

Experimental / Informatics

List of terms related to Vascular resistance

Template:WikiDoc Cardiology News Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Vascular resistance is a term used to define the resistance to flow that must be overcome to push blood through the circulatory system. The resistance offered by the peripheral circulation is known as the systemic vascular resistance (SVR), while the resistance offered by the vasculature of the lungs is known as the pulmonary vascular resistance (PVR). The systemic vascular resistance may also be referred to as the total peripheral resistance.

Units for measuring vascular resistance are dyn·s·cm-5 or pascal seconds per cubic metre (Pa·s/m³). Pediatric cardiologists use hybrid reference units (HRU), also known as Wood units, as they were introduced by Dr. Paul Wood. To convert from Wood units to MPa·s/m3 you must multiply by 8, or to dyn·s·cm-5 you must multiply by 80.

Measurement Reference Range
Systemic vascular resistance 900–1200 dyn·s/cm5 (90–120 MPa·s/m3)
Pulmonary vascular resistance 100–200 dyn·s/cm5 (10–20 MPa·s/m3)

Calculation of resistance

The basic tenet of calculating resistance is that flow is equal to driving pressure divided by resistance.

The pulmonary vascular resistance can therefore be calculated in units of dyn·s·cm-5 as

<math>\frac {80 \cdot (mean\ pulmonary\ arterial\ pressure - pulmonary\ capillary\ wedge\ pressure)} {cardiac\ output}</math>

where the pressures are measured in units of millimetres of mercury (mmHg) and the cardiac output is measured in units of litres per minute (L/min).

Determinants of vascular resistance

The major determinant of vascular resistance is small arteriolar (known as resistance arterioles) tone. These vessels are from 450 µm down to 100 µm in diameter. (As a comparison, the diameter of a capillary is about 3 to 4 µm.)

Another determinant of vascular resistance is the pre-capillary arterioles. These arterioles are less than 100 µm in diameter. They are sometimes known as autoregulatory vessels.

Regulation of vascular resistance

There are many factors that alter the vascular resistance. Many of the platelet-derived substances, including serotonin, are vasodilatory when the endothelium is intact and are vasoconstrictive when the endothelium is damaged.

Cholinergic stimulation causes release of endothelium-derived relaxing factor (EDRF) (later it was discovered that EDRF was nitric oxide) from intact endothelium, causing vasodilatation. If the endothelium is damaged, cholinergic stimulation causes vasoconstriction.

Role of adenosine

Adenosine probably doesn't play a role in maintaining the vascular resistance in the resting state. However, it causes vasodilatation and decreased vascular resistance during hypoxia. Adenosine is formed in the myocardial cells during hypoxia, ischemia, or vigorous work, due to the breakdown of high-energy phosphate compounds (e.g., adenosine monophosphate, AMP). Most of the adenosine that is produced leaves the cell and acts as a direct vasodilator on the vascular wall. Because adenosine acts as a direct vasodilator, it is not dependent on an intact endothelium to cause vasodilatation.

Adenosine causes vasodilatation in the small and medium sized resistance arterioles (less than 100 µm in diameter). When adenosine is administered it can cause a coronary steal phenomenon, where the vessels in healthy tissue dilate as much as the ischemic tissue and more blood is shunted away from the ischemic tissue that needs it most. This is the principle behind adenosine stress testing.

Adenosine is quickly broken down by adenosine deaminase, which is present in red cells and the vessel wall.

Coronary vascular resistance

The regulation of tone in the coronary arteries is a complex subject. There are a number of mechanisms for regulating coronary vascular tone, including metabolic demands (ie: hypoxia), neurologic control, and endothelial factors (ie: EDRF, endothelin).

Local metabolic control (based on metabolic demand) is the most important mechanism of control of coronary flow. Decreased tissue oxygen content and increased tissue CO2 content act as vasodilators Acidosis acts as a direct coronary vasodilator and also potentiates the actions of adenosine on the coronary vasculature.

References

1. Grossman W, Baim D. Grossman's Cardiac Catheterization, Angiography, and Intervention, Sixth Edition. Page 172, Tabe 8.1 ISBN 0-683-30741-X

See also


de:Gefäßwiderstand

Template:WikiDoc Sources